06.03.19
GERMANY: As part of its 2020 strategy to expand the capabilities of its active beauty business, Givaudan has reached an agreement to acquire the cosmetics business of AMSilk GmbH. The Munich-based firm is the first industrial supplier of vegan silk biopolymers.
AMSilk offers a range of high-performance biosourced polypeptides with unique functional properties in the field of cosmetics. These vegan biopolymers offer a broad range of applications across categories such as hair care and skin care with benefits like silk touch, anti-pollution, or color protection of the hair. The firm has filed 10 patents for the use of biopolymers in cosmetic applications.
“The acquisition of the cosmetics business of AMSilk fits very well with our long-term strategy for active beauty. It offers an expanded portfolio of natural and bio-sourced products supported by a strong research and development biotechnology platform to drive future development and innovation in the active cosmetic ingredients space. Their expertise in biotechnology is fully aligned with ours; it will reinforce Givaudan’s capabilities in cosmetic ingredients to support our customers in developing sustainable, performant and safe products,” said Maurizio Volpi, president of Givaudan’s Fragrance division.
Givaudan said it plans to fund the transaction from existing resources.
Terms of the deal have not been disclosed.
AMSilk offers a range of high-performance biosourced polypeptides with unique functional properties in the field of cosmetics. These vegan biopolymers offer a broad range of applications across categories such as hair care and skin care with benefits like silk touch, anti-pollution, or color protection of the hair. The firm has filed 10 patents for the use of biopolymers in cosmetic applications.
“The acquisition of the cosmetics business of AMSilk fits very well with our long-term strategy for active beauty. It offers an expanded portfolio of natural and bio-sourced products supported by a strong research and development biotechnology platform to drive future development and innovation in the active cosmetic ingredients space. Their expertise in biotechnology is fully aligned with ours; it will reinforce Givaudan’s capabilities in cosmetic ingredients to support our customers in developing sustainable, performant and safe products,” said Maurizio Volpi, president of Givaudan’s Fragrance division.
Givaudan said it plans to fund the transaction from existing resources.
Terms of the deal have not been disclosed.